To prescribe or not to prescribe? Atypical antipsychotic drugs in patients with dementia

Southern Medical Journal

Volumn 100, Issue 10, 2007, Pages 961-963

  Jeste, Dilip V ^a   Meeks, Thomas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

ALZHEIMER DISEASE; CLINICAL TRIAL; COST OF ILLNESS; DRUG COST; DRUG UTILIZATION; HUMAN; MORTALITY; NOTE; PRESCRIPTION; PSYCHOSIS; STROKE;

AGED; ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; DECISION MAKING; DEMENTIA; DRUG MONITORING; HUMANS; PATIENT CARE PLANNING; PATIENT PARTICIPATION; PRESCRIPTIONS, DRUG; PSYCHOMOTOR AGITATION; PSYCHOTIC DISORDERS; RISK ASSESSMENT; SAFETY; TREATMENT OUTCOME;

EID: 35148901608     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181514c51     Document Type: Note

References (13)

1. Hebert LE, Scherr PA, Bienias JL, et al. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 2003;60:1119-1122.
2. Ropacki SA, Jeste DV. Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003. Am J Psychiatry 2005;162:2022-2030.
3. Jeste DV, Meeks TW, Kim DS, et al. Research agenda for DSM-V: diagnostic categories and criteria for neuropsychiatry syndromes in dementia. J Geriatr Psychiatry Neurol 2006;19:160-171.
4. Jeste DV, Blazer D, Casey DE, et al. ACNP White Paper on the use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology 2007; Jul 18, EPub ahead of print.
5. Weiss E, Hummer M, Koller D, et al. Off-label use of antipsychotic drugs. J Clin Psychopharmacol 2000;20:695-698.
6. Jeste DV, Rockwell E, Harris MJ, et al. Conventional versus newer antipsychotics in elderly patients. Am J Geriatr Psychiatry 1999;7:70-76.
7. Schneider LS, Dagerman K, Insel PS. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 2006;14:191-210.
8. Cohen-Mansfield J. Nonpharmacologic interventions for inappropriate behaviors in dementia: a review and critique. Am J Geriatr Psychiatry 2001;9:361-381.
9. Livingston G, Johnston K, Katona C, et al. Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. Am J Psychiatry 2005;162:1996-2021.
10. Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional vs atypical antipsychotic medications. N Engl J Med 2005;353:2335-2341.
11. Nasrallah HA, White T, Nasrallah AT. Lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol: preliminary analysis of retrospective data. Am J Geriatr Psychiatry 2004; 12:437-439.
12. Gill SS, Bronskill SE, Normand ST, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007;146:775-786.
13. Shakespeare W. The Life of Henry the Fifth. Boston, DC Heath & Co, 1896.